Avitas Wealth Management LLC Has $8.56 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Avitas Wealth Management LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.3% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 16,806 shares of the healthcare conglomerate’s stock after selling 226 shares during the period. UnitedHealth Group comprises about 1.3% of Avitas Wealth Management LLC’s investment portfolio, making the stock its 16th largest holding. Avitas Wealth Management LLC’s holdings in UnitedHealth Group were worth $8,559,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of UNH. Bell Investment Advisors Inc grew its stake in shares of UnitedHealth Group by 4.8% during the fourth quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock valued at $276,000 after purchasing an additional 24 shares during the last quarter. Harbor Investment Advisory LLC lifted its stake in shares of UnitedHealth Group by 3.2% during the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after acquiring an additional 1,129 shares during the period. Austin Private Wealth LLC raised its holdings in UnitedHealth Group by 9.8% during the 1st quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $573,000 after purchasing an additional 111 shares during the last quarter. Vanguard Personalized Indexing Management LLC grew its position in shares of UnitedHealth Group by 7.9% during the 4th quarter. Vanguard Personalized Indexing Management LLC now owns 75,602 shares of the healthcare conglomerate’s stock worth $39,802,000 after buying an additional 5,537 shares during the period. Finally, Capital Insight Partners LLC boosted its stake in UnitedHealth Group by 3.8% in the first quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after acquiring an additional 332 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Morgan Stanley lifted their price objective on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Truist Financial lifted their price objective on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Barclays increased their target price on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Baird R W raised UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Finally, Royal Bank of Canada lifted their price objective on UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. One research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $614.17.

UnitedHealth Group Stock Up 1.0 %

UNH traded up $5.79 on Friday, hitting $584.51. 2,222,692 shares of the company were exchanged, compared to its average volume of 4,165,972. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. The stock’s fifty day moving average is $537.83 and its 200-day moving average is $509.96. The company has a market cap of $539.75 billion, a PE ratio of 35.73, a PEG ratio of 1.61 and a beta of 0.59. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $591.54.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. During the same period last year, the business earned $6.14 earnings per share. The firm’s revenue was up 6.4% on a year-over-year basis. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.44%. UnitedHealth Group’s dividend payout ratio is 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.